This research study is currently not recruiting patients.

A Double-Blind Randomized Controlled Dose Escalation Clinical Trial of an Antiplaque Chewing Gum- Phase 1 Safety and Tolerability and Phase 2a Safety Tolerability and Proof of Concept in a Gingivitis Population



Study Overview

purpose of this study is to see if chewing Antiplaque Chewing Gum is safe.


Study Description

purpose of this study is to see if chewing Antiplaque Chewing Gum is safe.

Research Study Identifier: TX3387
ClinicalTrials.gov Identifier: NCT1305011355
Principal Investigator: Domenick Zero, DDS, MS


Not Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.